Presentation Information
[P2-04]Considerations and Strategies for Biodistribution Assessment of Induced Pluripotent Stem Cell-derived Cell Therapy Products: A Case Study with Pancreatic Islet-like Cells
*Miyu Nakayama1, Yuu Moriya1, Hikaru Ueno2, Takeshi Watanabe1, Hideki Hirabayashi1, Syunsuke Yamamoto1 (1. Takeda Pharmaceutical Company Limited, 2. Orizuru Therapeutics, Inc.)
Keywords:
biodistribution,digital PCR,cell therapy
Password required to view
Log in
or